p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer (Q57338202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Berthold Gerdes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Annette Ramaswamy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Michael Kersting

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Renate Baumann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Anja Wild

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Roland Moll

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Matthias Rothmund

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sven A Lang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Detlef K Bartsch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

51-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer

5 December 2019

cites work

1 reference

12 December 2020

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

1 reference

12 December 2020

Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation

1 reference

12 December 2020

The National Cancer Data Base report on pancreatic cancer

1 reference

12 December 2020

Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas

1 reference

12 December 2020

Cathepsin D, B and L circulating levels as prognostic markers of malignant progression.

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma

1 reference

12 December 2020

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions

1 reference

12 December 2020

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

1 reference

12 December 2020

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

12 December 2020

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

12 December 2020

Evaluation of UICC TNM classification for pancreatic cancer

1 reference

12 December 2020

Mdm2: keeping p53 under control

1 reference

12 December 2020

Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer

1 reference

12 December 2020

Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival

1 reference

12 December 2020

Tests and estimates of allelic association in complex inheritance

1 reference

12 December 2020

The INK4a/ARF tumor suppressor: one gene--two products--two pathways

1 reference

12 December 2020

MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas

1 reference

12 December 2020

[The prognostic factors of pancreatic cancer--adhesion molecule CD44]

1 reference

12 December 2020

Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy

1 reference

12 December 2020

Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

1 reference

12 December 2020

Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker?

1 reference

12 December 2020

The cell cycle-regulating transcription factors E2F-RB.

1 reference

12 December 2020

Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.

1 reference

12 December 2020

Antioncogenes and human cancer

1 reference

12 December 2020

The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer

1 reference

12 December 2020

P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation

1 reference

12 December 2020

Hypermethylation of multiple genes in pancreatic adenocarcinoma

1 reference

12 December 2020

Adenovirus p16 gene therapy for prostate cancer

1 reference

12 December 2020

Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies

1 reference

12 December 2020

Molecular prognostic markers in pancreatic cancer

1 reference

12 December 2020

Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?

1 reference

12 December 2020

Collective review of small carcinomas of the pancreas

1 reference

12 December 2020

A genetic model for colorectal tumorigenesis

1 reference

12 December 2020

Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas

1 reference

12 December 2020

p53 mutations in human cancers

1 reference

12 December 2020

Surgical treatment of pancreatic cancer. The United States experience

1 reference

12 December 2020

Pancreatic adenocarcinomas frequently show p53 gene mutations.

1 reference

12 December 2020

Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma.

1 reference

12 December 2020

Overexpression of p53 protein in adenocarcinoma of the pancreas

1 reference

12 December 2020

Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene.

1 reference

12 December 2020

Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.

1 reference

12 December 2020

Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting

1 reference

12 December 2020

Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas

1 reference

12 December 2020

Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas

1 reference

12 December 2020

Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.

1 reference

12 December 2020

10.1097/00000658-200201000-00007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753042%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference